Lv1
40 积分 2021-12-06 加入
siRNA modification and delivery for drug development
1天前
待确认
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans
4天前
已完结
Specific renal delivery of sugar-modified low-molecular-weight peptides
6个月前
已关闭
皖公网安备34019202002308
